Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Pei Li Teh & An-hwa Lee
  • August 4, 2020
  • Webinars

Digital #MRX: How to use the latest technology to conduct market research in the age of COVID-19 and beyond

Digital #MRX: How to use the latest technology to conduct market research in the age of COVID-19 and beyond

Our experts explore some of the digital methodologies that can best be used to meet your research objectives throughout the product lifecycle.

Watch this webcast in which digital research experts Pei Li Teh and An-hwa Lee outline some of the digital methodologies that can best be used to meet your research objectives throughout the product lifecycle. From market assessment and understanding through to launching your brand and beyond. In particular, they focus on qualitative digital methods and discuss a range of tools from online communities and bulletin boards, virtual IDIs and groups, backroom brainstorms, WeChat and our proprietary mobile techniques Rx Potential, Rx Rationale and iComply. They also explore digital ethnography methods and platforms that are not only immersive and bring insights to life, but provide an additional depth of understanding.

read more »

Infographic - Emerging markets: Our experience and expertise

Infographic - Emerging markets: Our experience and expertise

Research Partnership has a dedicated team of healthcare research experts specialising in emerging markets with an established team of senior consultants, collaborating with you to deliver actionable and impactful insights that makes a difference to your business. Find out about our team of emerging market experts with this infographic outlining our experience and expertise across a vast number of regions.

read more »

  • Posted by Pei Li Teh & Colin Tan
  • June 19, 2020
  • Webinars

Agile is a mind-set not a methodology

Agile is a mind-set not a methodology

We’ve all heard about how important it is to be agile. And the focus in pharmaceutical market research has been mainly on speed, and the methodologies and techniques that get us faster results. But we believe there’s more to being agile than just toolkits and technology.

read more »

  • Posted by Pei Li Teh & Wan Ling Neo
  • November 15, 2019
  • Articles

Launching novel oncology therapies in Asia: Identifying and communicating value

Launching novel oncology therapies in Asia: Identifying and communicating value

Novel cancer therapies are offering patients new treatments and better outcomes worldwide. Recent changes in healthcare policies across APAC have reignited interest in the region as a strong market for oncology, such as China's fast tracking approval of therapies for severe and rare diseases and Vietnam's plan to cover health insurance for 80% of the population. Unfortunately, the often eye-watering costs of these new therapies means that, currently, for the many patients who still have to pay for treatment out of pocket, novel therapies are beyong reach. Pharma brands need to demonstate clear value if they want to achieve success. 

read more »

China: How to strategise and win in the world's fastest changing healthcare market

China: How to strategise and win in the world's fastest changing healthcare market

In this paper, our experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch a brand effectively in this exciting region.

With a population of 1.4 billion people China has always been an attractive prize to the pharmaceutical industry. However, China has historically been a tough market to crack and few multinational companies have seen a good return on their investment. But in 2019, the 70th anniversary of the communist party’s victory, the outlook has changed completely and now pharma is rushing to leverage the many opportunities that China offers.

read more »